CDCA5 and cancer: Cancers with elevated CDCA5 expression levels are associated with a dismal prognosis for overall survival (OS), such as ACC (P=2.5E-06), KIRC (P=0.0097), KIRP (P=0.0082), LGG (P=0.00026), LIHC (P=0.00021), LUAD (P=0.0056), MESO (P=9.7e-08), PAAD (P=0.024), PRAD (P=0.025), and SKCM (P=0.016) (Figure 3A; Figure 3B).